Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04960592 · ClinicalTrials.gov registry record
Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 61
- Enrollment target
NCT04960592: Completed study, sponsored by University of Arkansas.
NCT04960592 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04960592 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Spinal cord stimulation (SCS) is indicated for selected patients with chronic pain who have not responded to conventional medical management. Forty (40) patients indicated for SCS placement and presenting to the University of Arkansas for Medical Sciences (UAMS) Interventional Pain Management Clinic in Little Rock, Arkansas will be recruited for this study. Prior to temporary stimulator placement, patients will complete symptom-related questionnaires and provide a blood sample. Demographic and clinical characteristics will be obtained through medical record review. Patients will complete the same questionnaires and provide a blood sample at each of the routine clinical care follow-up visits.
Primary Outcome
Identification of genes that are associated with the resolution of pain
Interventions
- DEVICE Spinal Cord Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2024-07-01 |
What the finished NCT04960592 record still lists
NCT04960592 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.
NCT04960592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04960592 about?
NCT04960592 is a clinical study titled "Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation". Spinal cord stimulation (SCS) is indicated for selected patients with chronic pain who have not responded to conventional medical management. Forty (40) patients indicated for SCS placement and presenting to the University of Arkansas for Medical Sciences (UAMS) Interventional Pain Management Clini...
What is the current status of trial NCT04960592?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2021-02-15. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT04960592?
The interventions under investigation include: Spinal Cord Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04960592?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI